Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus

Joint Bone Spine

Volumn 78, Issue 2, 2011, Pages 124-130

  Richez, Christophe ^a,b,c   Blanco, Patrick ^a,b,c   Rifkin, Ian ^d   Moreau, Jean François ^a,b,c   Schaeverbeke, Thierry ^c  

^a CNRS Bordeaux Segalen University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Systemic lupus erythematosus; Toll like receptors

Indexed keywords

HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MYELOID DIFFERENTIATION FACTOR 88; PACLITAXEL; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; NONHUMAN; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 79952245823     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.09.005     Document Type: Short Survey

References (59)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Lemaitre B., Nicolas E., Michaut L., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
3. Imler J.L., Hoffmann J.A. Toll receptors in innate immunity. Trends Cell Biol 2001, 11:304-311.
4. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
5. Kawasaki K., Akashi S., Shimazu R., et al. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 2000, 275:2251-2254.
6. Kurt-Jones E.A., Popova L., Kwinn L., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401.
7. Rassa J.C., Meyers J.L., Zhang Y., et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A 2002, 99:2281-2286.
8. Vabulas R.M., Wagner H., Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 2002, 270:169-184.
9. Kokkola R., Andersson A., Mullins G., et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005, 61:1-9.
10. Park J.S., Svetkauskaite D., He Q., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004, 279:7370-7377.
11. Ulloa L., Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 2006, 17:189-201.
12. Urbonaviciute V., Furnrohr B.G., Meister S., et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008, 205:3007-3018.
13. Marshak-Rothstein A., Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007, 25:419-441.
14. Matsumoto M., Funami K., Tanabe M., et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003, 171:3154-3162.
15. Brentano F., Schorr O., Gay R.E., et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005, 52:2656-2665.
16. Diebold S.S., Kaisho T., Hemmi H., et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
17. Hemmi H., Takeuchi O., Kawai T., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
18. Yasuda K., Richez C., Uccellini M.B., et al. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J Immunol 2009, 183:3109-3117.
19. Cohen P.L., Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991, 9:243-269.
20. Lau C.M., Broughton C., Tabor A.S., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005, 202:1171-1177.
21. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285.
22. Bolland S., Yim Y.S., Tus K., et al. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 2002, 195:1167-1174.
23. Fukuyama H., Nimmerjahn F., Ravetch J.V. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 2005, 6:99-106.
24. Ehlers M., Fukuyama H., McGaha T.L., et al. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006, 203:553-561.
25. Silver K.L., Crockford T.L., Bouriez-Jones T., et al. MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur J Immunol 2007, 37:2734-2743.
26. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607.
27. Boule M.W., Broughton C., Mackay F., et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004, 199:1631-1640.
28. Means T.K., Latz E., Hayashi F., et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005, 115:407-417.
29. Vollmer J., Tluk S., Schmitz C., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005, 202:1575-1585.
30. Barrat F.J., Meeker T., Gregorio J., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005, 202:1131-1139.
31. Savarese E., Chae O.W., Trowitzsch S., et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells via TLR7. Blood 2006, 107:3229-3234.
32. Yasuda K., Richez C., Maciaszek J.W., et al. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 2007, 178:6876-6885.
33. Lande R., Gregorio J., Facchinetti V., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
34. Tian J., Avalos A.M., Mao S.Y., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8:487-496.
35. Avalos A.M., Kiefer K., Tian J., et al. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes. Autoimmunity 2010, 43:103-110.
36. Honda K., Yanai H., Negishi H., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
37. Honda K., Ohba Y., Yanai H., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035-1040.
38. Christensen S.R., Kashgarian M., Alexopoulou L., et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005, 202:321-331.
39. Wu X., Peng S.L. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 2006, 54:336-342.
40. Lartigue A., Courville P., Auquit I., et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol 2006, 177:1349-1354.
41. Yu P., Wellmann U., Kunder S., et al. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol 2006, 18:1211-1219.
42. Tao K., Fujii M., Tsukumo S., et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007, 66:905-909.
43. Christensen S.R., Shupe J., Nickerson K., et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006, 25:417-428.
44. Savarese E., Steinberg C., Pawar R.D., et al. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum 2008, 58:1107-1115.
45. Lee P.Y., Kumagai Y., Li Y., et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 2008, 205:2995-3006.
46. Subramanian S., Tus K., Li Q.Z., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A 2006, 103:9970-9975.
47. Richez C., Yasuda K., Bonegio R.G., et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J Immunol 2010, 184:796-806.
48. Deane J.A., Pisitkun P., Barrett R.S., et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007, 27:801-810.
49. Patole P.S., Grone H.J., Segerer S., et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 2005, 16:1326-1338.
50. Hang L., Slack J.H., Amundson C., et al. Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med 1983, 157:874-883.
51. Liu B., Yang Y., Dai J., et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol 2006, 177:6880-6888.
52. Lartigue A., Colliou N., Calbo S., et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol 2009, 183:6207-6216.
53. Castiblanco J., Varela D.C., Castano-Rodriguez N., et al. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol 2008, 8:541-544.
54. Graham R.R., Langefeld C.D., Gaffney P.M., et al. Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus. Arthritis Res 2001, 3:299-305.
55. Gilkeson G.S., Conover J., Halpern M., et al. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice. J Immunol 1998, 161:3890-3895.
56. Hasegawa K., Hayashi T. Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice. Lupus 2003, 12:838-845.
57. Gilkeson G.S., Ruiz P., Pippen A.M., et al. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 1996, 183:1389-1397.
58. Barrat F.J., Meeker T., Chan J.H., et al. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 2007, 37:3582-3586.
59. Pawar R.D., Patole P.S., Ellwart A., et al. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis. J Am Soc Nephrol 2006, 17:3365-3373.